{"id":"https://openalex.org/W2168225065","doi":"https://doi.org/10.1093/jac/dkf206","title":"Gamma-interferon treatment for resistant oropharyngeal candidiasis in an HIV-positive patient","display_name":"Gamma-interferon treatment for resistant oropharyngeal candidiasis in an HIV-positive patient","alternate_titles":[],"publication_year":2002,"publication_date":"2002-10-08","ids":{"openalex":"https://openalex.org/W2168225065","doi":"https://doi.org/10.1093/jac/dkf206","mag":"2168225065","pmid":"https://pubmed.ncbi.nlm.nih.gov/12407143"},"language":"en","primary_location":{"id":"doi:10.1093/jac/dkf206","doi":"https://doi.org/10.1093/jac/dkf206","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jac/dkf206","pdf_url":null,"source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2168225065"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060188638","display_name":"Neena Bodasing","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"N. Bodasing","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"R A Seaton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R A Seaton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"G S Shankland","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G S Shankland","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"A Pithie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A Pithie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5060188638"],"corresponding_institution_ids":[],"apc_list":{"value":2869,"currency":"GBP","value_usd":3784},"apc_paid":null,"fwci":0.8185,"has_fulltext":false,"cited_by_count":34,"citation_normalized_percentile":{"value":0.71477524,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"50","issue":"5","first_page":"765","last_page":"766"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9556000232696533,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9556000232696533,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13761","display_name":"HIV/AIDS oral health manifestations","score":0.03759999945759773,"subfield":{"id":"https://openalex.org/subfields/3500","display_name":"General Dentistry"},"field":{"id":"https://openalex.org/fields/35","display_name":"Dentistry"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11037","display_name":"Fungal Infections and Studies","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oropharyngeal-candidiasis","display_name":"oropharyngeal candidiasis","score":0.9950000047683716},{"id":"https://openalex.org/keywords/hiv-infection","display_name":"HIV infection","score":0.7889999747276306},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.8450000286102295},{"id":"https://openalex.org/keywords/azole-resistance","display_name":"azole resistance","score":0.6690000295639038},{"id":"https://openalex.org/keywords/fluconazole-resistance","display_name":"fluconazole resistance","score":0.8130000233650208},{"id":"https://openalex.org/keywords/candida-albicans","display_name":"Candida albicans","score":0.9229999780654907},{"id":"https://openalex.org/keywords/antifungal-prophylaxis","display_name":"antifungal prophylaxis","score":0.7210000157356262},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.6570000052452087},{"id":"https://openalex.org/keywords/opportunistic-infections","display_name":"opportunistic infections","score":0.5529999732971191},{"id":"https://openalex.org/keywords/mycobacterium-avium-infection","display_name":"Mycobacterium avium infection","score":0.7089999914169312},{"id":"https://openalex.org/keywords/bone-marrow-hypoplasia","display_name":"bone marrow hypoplasia","score":0.8560000061988831},{"id":"https://openalex.org/keywords/cd4-count-decline","display_name":"CD4 count decline","score":0.4970000088214874}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6095014214515686},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.583832859992981},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.38535547256469727},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.3715384900569916},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32060274481773376},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18997091054916382}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002180","descriptor_name":"Candidiasis, Oral","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D002180","descriptor_name":"Candidiasis, Oral","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006679","descriptor_name":"HIV Seropositivity","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D006679","descriptor_name":"HIV Seropositivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D025141","descriptor_name":"Drug Resistance, Fungal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1093/jac/dkf206","doi":"https://doi.org/10.1093/jac/dkf206","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jac/dkf206","pdf_url":null,"source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},{"id":"pmid:12407143","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12407143","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of antimicrobial chemotherapy","raw_type":"Case Reports"},{"id":"pmh:oai:open-archive.highwire.org:jac:dkf206v1","doi":null,"is_oa":false,"landing_page_url":"http://jac.oxfordjournals.org/cgi/content/short/dkf206v1","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W1967372096","https://openalex.org/W2003484888","https://openalex.org/W2132882111","https://openalex.org/W2133677080","https://openalex.org/W2150336680","https://openalex.org/W2395362254"],"related_works":["https://openalex.org/W2111029458","https://openalex.org/W2804130897","https://openalex.org/W2178196577","https://openalex.org/W2132981979","https://openalex.org/W1993783020","https://openalex.org/W2334099511","https://openalex.org/W1965472984","https://openalex.org/W1974126157","https://openalex.org/W1970474259","https://openalex.org/W2042143324"],"abstract_inverted_index":{"Sir,":[0],"Oropharyngeal":[1],"candidiasis":[2,58],"(OPC)":[3],"is":[4,15,25,362],"the":[5,29,45,92,380,405,497,547,552,562],"most":[6],"common":[7],"opportunistic":[8],"infection":[9,187,370],"occurring":[10],"in":[11,51,71,76,174,328,474,537,570],"HIV-infected":[12,393,538],"individuals.":[13],"Infection":[14],"often":[16],"recurrent,":[17],"requiring":[18],"long-term":[19],"prophylactic":[20,133],"antifungal":[21,418,485,573],"therapy.":[22,574],"Azole":[23],"resistance":[24],"a":[26,267,325,363,427],"problem,":[27],"and":[28,59,78,153,192,200,211,218,239,241,248,261,280,309,314,330,342,382,400,416,419,441,452,457,502,551],"molecular":[30],"mechanism":[31],"has":[32,384,413,460],"recently":[33],"been":[34,385,461,530],"discussed":[35],"by":[36,423,480,488,503,519,555],"Martinez":[37,556],"et":[38,557],"al.1":[39],"We":[40],"report":[41],"anecdotal":[42],"evidence":[43],"of":[44,47,98,139,166,206,270,319,332,340,349,379,407,435,449,491,500,505,535,564],"efficacy":[46],"subcutaneous":[48],"interferon-\u03b3":[49],"(IFN-\u03b3)":[50],"an":[52,375,484],"immunosuppressed":[53],"patient":[54,93,169,285,548,553],"with":[55,82,103,143,162,177,189,236,289,300,374,467,522,540,572],"drug-resistant":[56],"oropharyngeal":[57],"advanced":[60],"HIV":[61,69],"disease.":[62],"A":[63],"31-year-old":[64],"male":[65],"patient,":[66],"diagnosed":[67],"as":[68,132,546,568],"positive":[70],"1992,":[72],"first":[73],"experienced":[74,94],"OPC":[75,140,229],"1993":[77],"was":[79,112,130,170,195,208,215,221,243,273,293,324,335,347,353],"treated":[80,102,142],"successfully":[81],"oral":[83,104,144],"fluconazole":[84,105,126,256,276],"(200":[85,146,155],"mg/day":[86,107],"for":[87,108,135,150,159,398],"7":[88,216],"days).":[89,110],"In":[90,507],"1994":[91],"several":[95],"recurrent":[96],"episodes":[97],"OPC,":[99],"which":[100,481,495],"were":[101,141],"(200\u2013400":[106],"7\u201314":[109],"He":[111,194,225],"not":[113,232],"adherent":[114],"to":[115,172,183,227,234,245,251,275,296,310,409,463],"antiretroviral":[116,197,202],"therapy,":[117],"despite":[118],"worsening":[119],"immunosuppression":[120],"(CD4+":[121],"count":[122,214],"<100":[123],"cells/mm3).":[124],"Oral":[125],"50":[127],"mg":[128,147,156,303],"daily":[129,149,158],"commenced":[131],"therapy":[134,288,322,566],"OPC.":[136,333,542],"Further":[137],"recurrences":[138],"itraconazole":[145,262,281],"twice":[148],"21":[151],"days)":[152,161],"ketoconazole":[154],"once":[157],"14":[160],"only":[163],"partial":[164],"resolution":[165],"symptoms.":[167,351],"The":[168,284,477],"admitted":[171],"hospital":[173],"September":[175],"1998":[176],"profound":[178],"bone":[179],"marrow":[180],"hypoplasia":[181],"secondary":[182],"Mycobacterium":[184],"avium":[185],"(MAC)":[186],"(treated":[188],"clarithromycin,":[190],"rifampicin":[191],"ethambutol).":[193],"highly":[196],"drug":[198],"experienced,":[199],"his":[201,350],"regime":[203],"at":[204],"time":[205],"presentation":[207,437],"abacavir,":[209],"lamivudine":[210],"stavudine.":[212],"CD4+":[213],"cells/mm3":[217],"viral":[219],"load":[220],"48":[222],"000":[223],"copies/mL.":[224],"continued":[226],"have":[228,464,510,529],"that":[230,242,387,512],"did":[231],"respond":[233],"treatment":[235],"topical":[237,312],"nystatin":[238],"amphotericin,":[240],"found":[244],"be":[246,372],"clinically":[247],"microbiologically":[249],"resistant":[250],"azole":[252],"antifungals":[253],"[Candida":[254],"albicans:":[255],"MIC":[257,263],">":[258,264],"128":[259],"mg/L":[260],"16":[265],"mg/L;":[266],"pre-treatment":[268],"isolate":[269],"C.":[271],"albicans":[272],"susceptible":[274],"(MIC":[277],"2":[278],"mg/L)":[279],"(0.5":[282],"mg/L)].":[283],"refused":[286],"intravenous":[287],"amphotericin":[290,313,468],"B.":[291],"It":[292],"therefore":[294,354],"decided":[295],"stimulate":[297],"macrophage":[298,432],"function":[299],"IFN-\u03b3":[301,334,352,357,377,412,459,482,513,536,569],"1":[302],"three":[304],"times":[305],"weekly,":[306],"administered":[307],"subcutaneously,":[308],"continue":[311],"nystatin.":[315],"Within":[316],"3":[317],"weeks":[318],"commencing":[320],"this":[321],"there":[323,346,528],"dramatic":[326],"improvement":[327],"symptoms":[329],"signs":[331],"discontinued":[336],"after":[337],"4":[338,344],"months":[339],"treatment,":[341],"within":[343],"days":[345],"recurrence":[348],"reintroduced":[355],"successfully.":[356],"(a":[358],"T":[359],"cell-derived":[360],"lymphokine)":[361],"broadly":[364],"acting":[365],"host":[366,381],"defence-enhancing":[367],"cytokine.":[368],"Candida":[369],"may":[371,559],"associated":[373],"insufficient":[376],"response":[378],"it":[383],"demonstrated":[386,462,511],"peripheral":[388],"blood":[389],"mononuclear":[390],"cells":[391],"from":[392,561],"patients":[394,539,544],"show":[395],"decreased":[396],"ability":[397],"proliferative":[399],"differentiative":[401],"cytotoxic":[402],"responses":[403],"(including":[404],"production":[406,490],"IFN-\u03b3)":[408],"candidal":[410],"proteins.2":[411],"antineoplastic":[414],"effects":[415,453],"indirect":[417],"antiviral":[420],"activity":[421,466,499],"mediated":[422],"immunomodulatory":[424],"effects.":[425],"At":[426],"cellular":[428],"level":[429],"these":[430],"include":[431],"activation,":[433],"stimulation":[434],"antigen":[436],"through":[438],"class":[439,442],"I":[440],"II":[443],"major":[444],"histocompatibility":[445],"complex":[446],"molecules,":[447],"regulation":[448],"leucocyte\u2013endothelium":[450],"interaction,":[451],"on":[454],"cell":[455,517],"proliferation":[456],"apoptosis.3,4":[458],"synergic":[465],"B":[469],"against":[470],"intracellular":[471],"Cryptococcus":[472],"neoformans":[473],"animal":[475],"studies.5":[476],"proposed":[478],"mechanisms":[479],"exerts":[483],"effect":[486],"are":[487],"increasing":[489],"reactive":[492],"oxygen":[493],"radicals,":[494],"increases":[496],"candidacidal":[498],"granulocytes,":[501],"inhibition":[504],"phagocytosis.":[506],"vitro":[508],"studies":[509],"can":[514],"reduce":[515],"endothelial":[516,524],"phagocytosis":[518],"41.3%":[520],"compared":[521],"untreated":[523],"cells.6":[525],"As":[526],"yet":[527],"no":[531],"reported":[532],"clinical":[533],"trials":[534],"azole-resistant":[541],"These":[543],"(such":[545],"described":[549,554],"above":[550],"al.1)":[558],"benefit":[560],"use":[563],"immunological":[565],"such":[567],"combination":[571],"Corresponding":[575],"author.":[576],"Tel:":[577],"+44-141-211-1094;":[578],"Fax:":[579],"+44-141-211-1097;":[580],"E-mail:":[581],"neenabodasing@hotmail.com":[582],"1The":[583],"Brownlee":[584],"Centre,":[585],"Gartnavel":[586],"General":[587],"Hospital,":[588,608],"1053":[589],"Great":[590],"Western":[591,599],"Road,":[592,602],"Glasgow":[593,603],"G12":[594],"0YN;":[595],"2Mycology":[596],"Reference":[597],"Laboratory,":[598],"Infirmary,":[600],"Dumbarton":[601],"G11":[604],"6NT,":[605],"UK;":[606],"3Christchurch":[607],"Private":[609],"Bag":[610],"4710,":[611],"Christchurch,":[612],"New":[613],"Zealand":[614]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2168225065","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
